Article
Association between theFCGR3AV158F polymorphism and the clinical response to infliximab in rheumatoid arthritis and spondyloarthritis patients
21 Jun 2010
Abstract excerpt
Besides the therapeutic effect of infliximab by the blocking of soluble tumour necrosis factor (TNF), current evidence indicates that membrane-bound TNF is also a target of infliximab and therefore...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
